Antagonism of nicotinic acetylcholine receptors by inhibitors of monoamine uptake

Mol Psychiatry. 2001 Sep;6(5):511-9. doi: 10.1038/sj.mp.4000885.

Abstract

A study was made of the effects of several monoamine-uptake inhibitors on membrane currents elicited by acetylcholine (ACh-currents) generated by rat neuronal alpha2beta4 and mouse muscle nicotinic acetylcholine receptors (AChRs) expressed in Xenopus laevis oocytes. For the two types of receptors the monoamine-uptake inhibitors reduced the ACh-currents albeit to different degrees. The order of inhibitory potency was norfluoxetine > clomipramine > indatraline > fluoxetine > imipramine > zimelidine > 6-nitro-quipazine > trazodone for neuronal alpha2beta4 AChRs, and norfluoxetine > fluoxetine > imipramine > clomipramine > indatraline > zimelidine > trazodone > 6-nitro-quipazine for muscle AChRs. Thus, the most potent inhibitor was norfluoxetine, whilst the weakest ones were trazodone, 6-nitro-quipazine and zimelidine. Effects of the tricyclic antidepressant imipramine were studied in more detail. Imipramine inhibited reversibly and non-competitively the ACh-current with a similar inhibiting potency for both neuronal alpha2beta4 and muscle AChRs. The half-inhibitory concentrations of imipramine were 3.65 +/- 0.30 microM for neuronal alpha2beta4 and 5.57 +/- 0.19 microM for muscle receptors. The corresponding Hill coefficients were 0.73 and 1.2 respectively. The inhibition of imipramine was slightly voltage-dependent, with electric distances of approximately 0.10 and approximately 0.12 for neuronal alpha2beta4 and muscle AChRs respectively. Moreover, imipramine accelerated the rate of decay of ACh- currents of both muscle and neuronal AChRs. The ACh-current inhibition was stronger when oocytes, expressing neuronal alpha2beta4 or muscle receptors, were preincubated with imipramine alone than when it was applied after the ACh-current had been generated, suggesting that imipramine acts also on non-activated or closed AChRs. We conclude that monoamine-uptake inhibitors reduce ACh-currents and that imipramine regulates reversibly and non- competitively neuronal alpha2beta4 and muscle AChRs through similar mechanisms, perhaps by interacting externally on a non-conducting state of the AChR and by blocking the open receptor-channel complex close to the vestibule of the channel. These studies may be important for understanding the regulation of AChRs as well as for understanding antidepressant- and side-effects of monoamine-uptake inhibitors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcholine / pharmacology
  • Animals
  • Antidepressive Agents / pharmacology*
  • Biogenic Monoamines / antagonists & inhibitors
  • Biogenic Monoamines / metabolism
  • Female
  • Fluoxetine / pharmacology
  • Imipramine / pharmacology
  • Membrane Potentials / drug effects
  • Membrane Potentials / physiology
  • Muscle, Skeletal / physiology
  • Neurons / physiology
  • Neurotransmitter Uptake Inhibitors / pharmacology*
  • Oocytes / drug effects
  • Oocytes / physiology
  • Protein Subunits
  • Rats
  • Receptors, Nicotinic / drug effects
  • Receptors, Nicotinic / genetics
  • Receptors, Nicotinic / physiology*
  • Recombinant Proteins / drug effects
  • Recombinant Proteins / metabolism
  • Xenopus laevis
  • Zimeldine / pharmacology

Substances

  • Antidepressive Agents
  • Biogenic Monoamines
  • Neurotransmitter Uptake Inhibitors
  • Protein Subunits
  • Receptors, Nicotinic
  • Recombinant Proteins
  • Fluoxetine
  • Zimeldine
  • Acetylcholine
  • Imipramine